Close
29 May 2017
Late last year the Australian Health Workforce Ministerial Council (Ministerial Council) endorsed the AHMAC Guidance for National Boards: Applications to the Ministerial Council for approval of endorsements in relation to scheduled medicines under section 14 of the National Law (the Guidance).
The Guidance is published on the AHPRA website under Ministerial directives and communiques. It provides information for National Boards about the process for, and content of, an application to the Ministerial Council for approval of endorsement for scheduled medicines for a health profession under section 14 of the National Law.
Consistent with the Guidance, AHPRA has established a Scheduled Medicines Expert Committee (Expert Committee) whose role is to advise National Boards on the use of scheduled medicines generally, and on matters relevant to a National Board’s proposal for a new scheduled medicines endorsement or an amendment to an existing scheduled medicines endorsement. Following a call for applications, AHPRA is pleased to announce the following appointments to the Expert Committee:
The Expert Committee is expected to hold its inaugural meeting later this year. Information about the Expert Committee, including the Terms of Reference will be published on the AHPRA website shortly.